Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplant Recipients.

NCT00305396 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00305396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00305396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplant Recipients.
Lead sponsor
Vanderbilt University
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2004
Completion date
March 31, 2005
Enrollment
80
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation